nach oben

Diabetologia

Erschienen in:

01.10.2011 | Article

Restoration of hepatic glycogen deposition reduces hyperglycaemia, hyperphagia and gluconeogenic enzymes in a streptozotocin-induced model of diabetes in rats

verfasst von: S. Ros, M. García-Rocha, J. Calbó, J. J. Guinovart

Erschienen in: Diabetologia | Ausgabe 10/2011

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Glycogen deposition is impaired in diabetes, thus contributing to the development of hyperglycaemia. Several glucose-lowering strategies have attempted to increase liver glycogen deposition by modulating targets, which eventually trigger the activation of liver glycogen synthase (LGS). However, these targets also alter several other biological processes, and therefore their therapeutic use may be limited. Here we tested the approach of directly activating LGS and evaluated the potential of this strategy as a possible treatment for diabetes.

Methods

In this study, we examined the efficacy of directly overproducing a constitutively active form of LGS in the liver to ameliorate streptozotocin-induced diabetes in rats.

Results

Activated mutant LGS overproduction in the liver of streptozotocin-induced diabetic rats normalised liver glycogen content, despite low levels of glucokinase and circulating insulin. Moreover, this overproduction led to a decrease in food intake and in the production of the main gluconeogenic enzymes, glucose-6-phosphatase, fructose-1,6-bisphosphatase and phosphoenolpyruvate carboxykinase. The resulting combined effect was a reduction in hyperglycaemia.

Conclusions/interpretation

The restoration of liver glycogen ameliorated diabetes and therefore is considered a potential strategy for the treatment of this disease.

Roach PJ, Cheng C, Huang D et al (1998) Novel aspects of the regulation of glycogen storage. J Basic Clin Physiol Pharmacol 9:139–151PubMedCrossRef

Magnusson I, Rothman DL, Katz LD, Shulman RG, Shulman GI (1992) Increased rate of gluconeogenesis in type II diabetes mellitus. A ¹³C nuclear magnetic resonance study. J Clin Invest 90:1323–1327PubMedCrossRef

Cline GW, Rothman DL, Magnusson I, Katz LD, Shulman GI (1994) ¹³C-nuclear magnetic resonance spectroscopy studies of hepatic glucose metabolism in normal subjects and subjects with insulin-dependent diabetes mellitus. J Clin Invest 94:2369–2376PubMedCrossRef

Velho G, Petersen KF, Perseghin G et al (1996) Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J Clin Invest 98:1755–1761PubMedCrossRef

O’Doherty RM, Lehman DL, Telemaque-Potts S, Newgard CB (1999) Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia. Diabetes 48:2022–2027PubMedCrossRef

Baker DJ, Greenhaff PL, MacInnes A, Timmons JA (2006) The experimental type 2 diabetes therapy glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction. Diabetes 55:1855–1861PubMedCrossRef

Gasa R, Clark C, Yang R, DePaoli-Roach AA, Newgard CB (2002) Reversal of diet-induced glucose intolerance by hepatic expression of a variant glycogen-targeting subunit of protein phosphatase-1. J Biol Chem 277:1524–1530PubMedCrossRef

Yang R, Newgard CB (2003) Hepatic expression of a targeting subunit of protein phosphatase-1 in streptozotocin-diabetic rats reverses hyperglycemia and hyperphagia despite depressed glucokinase expression. J Biol Chem 278:23418–23425PubMedCrossRef

Ros S, Garcia-Rocha M, Dominguez J, Ferrer JC, Guinovart JJ (2009) Control of liver glycogen synthase activity and intracellular distribution by phosphorylation. J Biol Chem 284:6370–6378PubMedCrossRef

10.

Ros S, Zafra D, Valles-Ortega J et al (2010) Hepatic overexpression of a constitutively active form of liver glycogen synthase improves glucose homeostasis. J Biol Chem 285:37170–37177PubMedCrossRef

11.

Gomis RR, Ferrer JC, Guinovart JJ (2000) Shared control of hepatic glycogen synthesis by glycogen synthase and glucokinase. Biochem J 351:811–816PubMedCrossRef

12.

Becker TC, Noel RJ, Coats WS et al (1994) Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol 43:161–189PubMedCrossRef

13.

Cid E, Gomis RR, Geremia RA, Guinovart JJ, Ferrer JC (2000) Identification of two essential glutamic acid residues in glycogen synthase. J Biol Chem 275:33614–33621PubMedCrossRef

14.

Massague J, Guinovart JJ (1977) Insulin control of rat hepatocyte glycogen synthase and phosphorylase in the absence of glucose. FEBS Lett 82:317–320PubMedCrossRef

15.

Thomas JA, Schlender KK, Larner J (1968) A rapid filter paper assay for UDPglucose–glycogen glucosyltransferase, including an improved biosynthesis of UDP-¹⁴C-glucose. Anal Biochem 25:486–499PubMedCrossRef

16.

Chan TM, Exton JH (1976) A rapid method for the determination of glycogen content and radioactivity in small quantities of tissue or isolated hepatocytes. Anal Biochem 71:96–105PubMedCrossRef

17.

Garcia-Rocha M, Roca A, de la Iglesia N et al (2001) Intracellular distribution of glycogen synthase and glycogen in primary cultured rat hepatocytes. Biochem J 357:17–24PubMedCrossRef

18.

de la Iglesia N, Veiga-da-Cunha M, van Schaftingen E, Guinovart JJ, Ferrer JC (1999) Glucokinase regulatory protein is essential for the proper subcellular localisation of liver glucokinase. FEBS Lett 456:332–338PubMedCrossRef

19.

Gomis RR, Cid E, Garcia-Rocha M, Ferrer JC, Guinovart JJ (2002) Liver glycogen synthase but not the muscle isoform differentiates between glucose 6-phosphate produced by glucokinase or hexokinase. J Biol Chem 277:23246–23252PubMedCrossRef

20.

Gomis RR, Favre C, Garcia-Rocha M, Fernandez-Novell JM, Ferrer JC, Guinovart JJ (2003) Glucose 6-phosphate produced by gluconeogenesis and by glucokinase is equally effective in activating hepatic glycogen synthase. J Biol Chem 278:9740–9746PubMedCrossRef

21.

Trinh KY, O’Doherty RM, Anderson P, Lange AJ, Newgard CB (1998) Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats. J Biol Chem 273:31615–31620PubMedCrossRef

22.

Herz J, Gerard RD (1993) Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci USA 90:2812–2816PubMedCrossRef

23.

Burcelin R, Eddouks M, Kande J, Assan R, Girard J (1992) Evidence that GLUT-2 mRNA and protein concentrations are decreased by hyperinsulinaemia and increased by hyperglycaemia in liver of diabetic rats. Biochem J 288:675–679PubMed

24.

Doherty MJ, Cadefau J, Stalmans W, Bollen M, Cohen PT (1998) Loss of the hepatic glycogen-binding subunit (GL) of protein phosphatase 1 underlies deficient glycogen synthesis in insulin-dependent diabetic rats and in adrenalectomized starved rats. Biochem J 333:253–257PubMed

25.

Browne GJ, Delibegovic M, Keppens S, Stalmans W, Cohen PT (2001) The level of the glycogen targetting regulatory subunit R5 of protein phosphatase 1 is decreased in the livers of insulin-dependent diabetic rats and starved rats. Biochem J 360:449–459PubMedCrossRef

26.

Rao PV, Pugazhenthi S, Khandelwal RL (1995) The effects of streptozotocin-induced diabetes and insulin supplementation on expression of the glycogen phosphorylase gene in rat liver. J Biol Chem 270:24955–24960PubMedCrossRef

27.

Iynedjian PB (1993) Mammalian glucokinase and its gene. Biochem J 293:1–13PubMed

28.

Cherrington AD (1999) Banting Lecture, 1997. Control of glucose uptake and release by the liver in vivo. Diabetes 48:1198–1214PubMedCrossRef

29.

Sindelar DK, Havel PJ, Seeley RJ, Wilkinson CW, Woods SC, Schwartz MW (1999) Low plasma leptin levels contribute to diabetic hyperphagia in rats. Diabetes 48:1275–1280PubMedCrossRef

30.

Mayer J (1953) Glucostatic mechanism of regulation of food intake. N Engl J Med 249:13–16PubMedCrossRef

31.

Russek M (1963) Participation of hepatic glucoreceptors in the control of intake of food. Nature 197:79–80PubMedCrossRef

32.

Tordoff MG, Friedman MI (1988) Hepatic control of feeding: effect of glucose, fructose, and mannitol infusion. Am J Physiol 254:R969–R976PubMed

33.

Tordoff MG, Tluczek JP, Friedman MI (1989) Effect of hepatic portal glucose concentration on food intake and metabolism. Am J Physiol 257:R1474–R1480PubMed

34.

Mayer J (1991) Bulletin of the New England Medical Center, Volume XIV, April–June 1952: the glucostatic theory of regulation of food intake and the problem of obesity (a review). Nutr Rev 49:46–48PubMedCrossRef

35.

Flatt JP (1996) Carbohydrate balance and body-weight regulation. Proc Nutr Soc 55:449–465PubMedCrossRef

36.

Winnick JJ, An Z, Ramnanan CJ et al (2011) Hepatic glycogen supercompensation activates AMP-activated protein kinase, impairs insulin signaling, and reduces glycogen deposition in the liver. Diabetes 60:398–407PubMedCrossRef

37.

Granner D, Pilkis S (1990) The genes of hepatic glucose metabolism. J Biol Chem 265:10173–10176PubMed

38.

Cline GW, Johnson K, Regittnig W et al (2002) Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats. Diabetes 51:2903–2910PubMedCrossRef

39.

Ring DB, Johnson KW, Henriksen EJ et al (2003) Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes 52:588–595PubMedCrossRef

40.

Lochhead PA, Coghlan M, Rice SQ, Sutherland C (2001) Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression. Diabetes 50:937–946PubMedCrossRef

41.

Coghlan MP, Culbert AA, Cross DA et al (2000) Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol 7:793–803PubMedCrossRef

42.

Irimia JM, Meyer CM, Peper CL et al (2010) Impaired glucose tolerance and predisposition to the fasted state in liver glycogen synthase knock-out mice. J Biol Chem 285:12851–12861PubMedCrossRef

Titel: Restoration of hepatic glycogen deposition reduces hyperglycaemia, hyperphagia and gluconeogenic enzymes in a streptozotocin-induced model of diabetes in rats
verfasst von: S. Ros
M. García-Rocha
J. Calbó
J. J. Guinovart
Publikationsdatum: 01.10.2011
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 10/2011
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-011-2238-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2011

Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids

C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes

Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations

Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol

Identification of an intracellular metabolic signature impairing beta cell function in the rat beta cell line INS-1E and human islets